Objective: Conjugated linoleic acid (CLA) has long been recognized to exert protective effects
on carcinogenesis in breast, prostate and colon malignancies. Recent data suggests
that CLA plays a key role in inhibiting several important survival pathways in breast
carcinoma cell lines. However, data on effects of CLA in epithelial ovarian carcinoma
are lacking and was the focus of this study.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gynecologic OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2010 Published by Elsevier Inc.
